H.R. 8698 · 118th Congress · Health
SCREEN for Type 1 Diabetes Act of 2024
- IntroducedJun 11, 2024 Done
- CommitteeDied Jan 3, 2025 Stopped here
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.Who lobbies on it
1 organization · 2 filings · Q2 2024–Q4 2024One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Sanofi Us Services Inc
2 of 3 quarters
“…issues related to HR 8698 and S.4504 "SCREEN for Type 1 Diabetes"; issues related to HRSA - Type 1 Diabetes Screening; general issues related to Inflation Reduction Act; issues related to March-In rights; and issues related to Routine Immunizations Rates.”
$5.5M lobbying spend in 2024, all issuesQ3 2024 filing
Organizations that named H.R. 8698 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Jun 11, 2024Referred to the House Committee on Energy and Commerce.
- Jun 11, 2024Introduced in House